Report Code : CVMI24071655 | Published Date : July 16, 2024
The Iron Deficiency Anemia Treatment Market is witnessing steady growth, driven by rising prevalence of anemia, increasing awareness of iron supplementation, and advancements in intravenous (IV) iron therapy. The market, valued at USD 3.21 billion in 2023, is projected to grow at a CAGR of 5.45% from 2024 to 2031, reaching USD 5.29 billion by 2031.
Key Market Insights
Iron deficiency anemia, characterized by low hemoglobin levels due to insufficient iron, affects millions worldwide. The demand for oral iron supplements, IV iron formulations, and dietary interventions is increasing, particularly among pregnant women, children, and the elderly populations.
Growth Drivers
- Rising Global Anemia Cases and Nutritional Deficiencies – The increasing prevalence of iron deficiency in both developing and developed nations is driving demand.
- Advancements in IV Iron Therapy and Bioavailable Oral Iron Supplements – The introduction of nanoparticle iron supplements and improved IV iron compounds enhances treatment efficacy.
- Government Initiatives and Public Health Awareness Campaigns – Programs that promote fortified foods, provide iron supplementation, and conduct anemia screening are driving the market expansion.
- Growing Adoption of Personalized Anemia Treatment Plans – The development of targeted iron therapy based on individual deficiencies is enhancing treatment outcomes.
Regional Trends
- North America excels because of its robust healthcare infrastructure and heightened awareness of anemia management.
- Europe is growing through government-backed nutrition programs and clinical research in iron therapy.
- The Asia-Pacific region is experiencing rapid growth due to the high prevalence of anemia and the rising use of iron supplements initiatives.
- Latin America and MEA are emerging markets benefiting from growing public health initiatives for anemia prevention programs.
Analyst View
The Iron Deficiency Anemia Treatment Market is set for continuous expansion, driven by advancements in iron supplement formulations, increasing public health initiatives, and rising awareness of anemia. Companies investing in bioavailable iron compounds, AI-driven anemia diagnostics, and personalized nutrition solutions will dominate this evolving sector.
Reasons To Buy

Scope

Key Players
- Vifor Pharma Group
- AMAG Pharmaceuticals
- Inc.
- Daiichi Sankyo Company
- Limited
- Pfizer Inc.
- Pharmacosmos A/S
Iron Deficiency Anemia Treatment Market Report
- 1. Iron Deficiency Anemia Treatment Market Research Report
- 1.1 Study Objectives
- 1.2 Iron Deficiency Anemia Treatment Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Iron Deficiency Anemia Treatment Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Type
- 2.1.2 By Patient Type
- 2.1.3 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Type, By Patient Type, By Country
- 3.3. Opportunities – By Type, By Patient Type, By Country
- 3.4. Trends – By Type, By Patient Type, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Iron Deficiency Anemia Treatment Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Oral Iron Supplements
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Intravenous Iron Supplements
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Adults
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Children
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 North America
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Europe
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Asia-Pacific
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.4 Latin America
- 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.5 Middle East & Africa
- 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.6 Iron Deficiency Anemia Treatment Market - Opportunity Analysis Index, By Type, By Patient Type, and Region, 2024 - 2031
- 8.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 8.1.1 Oral Iron Supplements
- 8.1.2 Intravenous Iron Supplements
- 8.2.1 Adults
- 8.2.2 Children
- 8.3.1 United States
- 8.3.2 Canada
8.5 Regional Trends Analysis
8.6 North America Iron Deficiency Anemia Treatment Market Research Report - Company Profiles- 8.6.1 Company 1 (United States)
- 8.6.2 Company 2 (Canada)
- 8.6.3 Company 3 (Canada)
- 9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Oral Iron Supplements
- 9.1.2 Intravenous Iron Supplements
- 9.2.1 Adults
- 9.2.2 Children
- 9.3.1 Germany
- 9.3.2 United Kingdom
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Russia
- 9.3.7 Netherlands
- 9.3.8 Poland
- 9.3.9 Rest of Europe
9.5 Regional Trends Analysis
9.6 Europe Iron Deficiency Anemia Treatment Market Research Report - Company Profiles- 9.6.1 Company 1 (Germany)
- 9.6.2 Company 2 (United Kingdom)
- 9.6.3 Company 3 (United Kingdom)
- 10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Oral Iron Supplements
- 10.1.2 Intravenous Iron Supplements
- 10.2.1 Adults
- 10.2.2 Children
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia & NZ
- 10.3.6 ASEAN
- 10.3.7 Rest of Asia-Pacific
10.5 Regional Trends Analysis
10.6 Asia-Pacific Iron Deficiency Anemia Treatment Market Research Report - Company Profiles- 10.6.1 Company 1 (China)
- 10.6.2 Company 2 (Japan)
- 10.6.3 Company 3 (Japan)
- 11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Oral Iron Supplements
- 11.1.2 Intravenous Iron Supplements
- 11.2.1 Adults
- 11.2.2 Children
- 11.3.1 Brazil
- 11.3.2 Mexico
- 11.3.3 Argentina
- 11.3.4 Peru
- 11.3.5 Colombia
- 11.3.6 Rest of Latin America
11.5 Regional Trends Analysis
11.6 Latin America Iron Deficiency Anemia Treatment Market Research Report - Company Profiles- 11.6.1 Company 1 (Brazil)
- 11.6.2 Company 2 (Mexico)
- 11.6.3 Company 3 (Mexico)
- 12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Oral Iron Supplements
- 12.1.2 Intravenous Iron Supplements
- 12.2.1 Adults
- 12.2.2 Children
- 12.3.1 Saudi Arabia
- 12.3.2 UAE
- 12.3.3 South Africa
- 12.3.4 Egypt
- 12.3.5 Israel
- 12.3.6 Rest of Middle East and Africa
12.5 Regional Trends Analysis
12.6 Middle East & Africa Iron Deficiency Anemia Treatment Market Research Report - Company Profiles- 12.6.1 Company 1 (Saudi Arabia)
- 12.6.2 Company 2 (UAE)
- 12.6.3 Company 3 (UAE)
- 13.1 Strategic Dashboard of Top Market Players
13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 13.2.1 Vifor Pharma Group
- 13.2.2 AMAG Pharmaceuticals
- 13.2.3 Inc.
- 13.2.4 Daiichi Sankyo Company
- 13.2.5 Limited
- 13.2.6 Pfizer Inc.
- 13.2.7 Pharmacosmos A/S
15. Principal Presumptions and Acronyms